APGE News
Archived Headlines
- Inflammatory disease biotech Apogee Therapeutics prices upsized IPO at $17 high end 07/14/23
- Biotechs Apogee and Sagimet slated to kick off the July IPO market 07/11/23
- Inflammatory disease biotech Apogee Therapeutics sets terms for $250 million IPO 07/10/23
- US IPO Week Ahead: Surf Air Mobility slated to complete the first direct listing of 2023 07/07/23
- US IPO Weekly Recap: The summer calendar starts to fill up 06/23/23
See more
Here's what the top-performing IPOs of 2023 tell us about 2024
Get ready for a bevy of biotech IPOs. The 30 IPOs that raised $100 million or more in 2023 currently average a strong 25% return from offer, thanks to solid first day gains (+14%) that have built in the aftermarket (+9%). ...read more
Updated: Renaissance Capital's 3Q 2023 US IPO Market Review
Large Tech IPOs Stage a Comeback in a Volatile 3Q The third quarter of 2023 produced 30 IPOs that raised a combined $7.8 billion, more than the proceeds raised in the full-year 2022 despite no...read more
Renaissance Capital's July IPO Market Update
Eleven issuers raised a combined $939 million in July, well below the 10-year average (22 IPOs, $5.1B). Four deals raised $80 million or more, along with the year’s first direct listing (SRFM), and a wave of small issuers, which have largely disappeared...read more
US IPO Weekly Recap: July IPO market kicks off with sizable biotechs
Following the Independence Day lull, the July IPO market warmed up with two sizable biotechs, joined by two blank check...read more